Medicinal Products

Sildenafil Pliva 20 mg filmom obložene tablete

Name Sildenafil Pliva 20 mg filmom obložene tablete
Marketing Authorisation Number HR-H-575973033
Active Substance sildenafilcitrat
Composition jedna filmom obložena tableta sadrži 20 mg sildenafila (u obliku sildenafilcitrata)
Pharmaceutical Form filmom obložena tableta
Packaging [MA Number for Packaging] 30 tableta u blisteru, u kutiji  [HR-H-575973033-01]
90 tableta u blisteru, u kutiji  [HR-H-575973033-02]
300 tableta u blisteru, u kutiji  [HR-H-575973033-03]
90 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-575973033-04]
Manufacturer Teva Operations Poland Sp. z o.o., Krakow, Poljska
Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka
Teva Pharma B.V., Haarlem, Nizozemska
Pliva Hrvatska d.o.o., Zagreb, Hrvatska
Marketing Authorisation Holder Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska
Marketing Authorisation Date 27.01.2021
MA Period of Validity unlimited
Classification Number UP/I-530-09/20-02/124
Registration Number 381-12-01/30-21-03
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code G04BE03
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o prijevremeno prekinutom kliničkom ispitivanju primjene sildenafila za liječenje intrauterinog zastoja rasta 16.10.2018 Alpha-Medical d.o.o., Belupo lijekovi i kozmetika d.d., Krka – farma d.o.o., Pfizer Croatia d.o.o., PharmaS d.o.o., Pliva Hrvatska d.o.o. i Sandoz d.o.o.
Back